Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Adrenal Insufficiency × Prednisolone × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Lymphoma 34 Precursor Cell Lymphoblastic Leukemia-Lymphoma 25 Prostatic Neoplasms 21 Lymphoma, Large B-Cell, Diffuse 21 Leukemia 14 Lymphoma, Follicular 12 Lymphoma, Non-Hodgkin 11 Hodgkin Disease 9 Burkitt Lymphoma 8 Neoplasm Metastasis 6 Leukemia, Biphenotypic, Acute 6 Recurrence 5 Lymphoma, B-Cell 5 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4 Lymphoma, Large-Cell, Anaplastic 4 Ovarian Neoplasms 3 Neoplasms 3 Multiple Myeloma 3 Lymphoma, Large-Cell, Immunoblastic 3 Immunoblastic Lymphadenopathy 3 Hemangioma 3 Dendritic Cell Sarcoma, Interdigitating 3 Breast Neoplasms 3 Neurotoxicity Syndromes 2 Neoplasm, Residual 2 Myasthenia Gravis 2 Lymphoma, T-Cell 2 Lymphoma, Mantle-Cell 2 Lymphoma, B-Cell, Marginal Zone 2 Endometrial Neoplasms 2

Interventions

ravulizumab 1 Saline Solution 1 Prednisone 1 Prednisolone 1 Hydrocortisone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07221838 2026-03-03

OCTAGON

Alexion Pharmaceuticals, Inc.

Phase 4 Not yet recruiting

Adrenal Insufficiency, Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡